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BACKGROUND: Dynamic contrast-enhanced magnetic resonance imaging (DCE MRI) can characterize perfusion
and vascularization of tissues. DCE MRI parameters can differentiate between malignant and benign lesions and
predict tumor grading. The purpose of this study was to correlate DCE MRI findings and various histopathological
parameters in head and neck squamous cell carcinoma (HNSCC). PATIENTS AND METHODS: Sixteen patients with
histologically proven HNSCC (11 cases primary tumors and in 5 patients with local tumor recurrence) were
included in the study. DCE imaging was performed in all cases and the following parameters were estimated:
K trans, Ve, Kep, and iAUC. The tumor proliferation index was estimated on Ki 67 antigen stained specimens.
Microvessel density parameters (stained vessel area, total vessel area, number of vessels, and mean vessel
diameter) were estimated on CD31 antigen stained specimens. Spearman's non-parametric rank sum correlation
coefficients were calculated between DCE and different histopathological parameters. RESULTS: The mean values
of DCE perfusion parameters were as follows: K trans 0.189 ± 0.056 min−1, Kep 0.390 ± 0.160 min
−1, Ve 0.548 ±
0.119%, and iAUC 22.40 ± 12.57. Significant correlations were observed between Kep and stained vessel areas
(r = 0.51, P = .041) and total vessel areas (r = 0.5118, P = .043); between Ve and mean vessel diameter (r =
−0.59, P = .017). Cell count had a tendency to correlate with Ve (r = −0.48, P= .058). In an analysis of the primary
HNSCC only, a significant inverse correlation between K trans and KI 67 was identified (r = −0.62, P = .041). Our
analysis showed significant correlations between DCE parameters and histopathological findings in HNSCC.
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http://dx.doi.org/10.1016/j.tranon.2016.10.001Dynamic contrast-enhanced magnetic resonance imaging (DCE
MRI) has been reported as a technique which is able to characterize
perfusion and vascularization of tissues [1,2]. It has been shown that
DCE MRI can be helpful to differentiate between malignant and
benign lesions [1]. For example, Yuan et al. reported that lung cancer
had a larger volume transfer constant (K trans) and a lower volume of
the extravascular extracellular leakage space (Ve) in comparison to
benign lesions [3]. Similar results were reported by Li et al. for breast
lesions [4]. Furthermore, according to Cho et al., DCE MRI
parameters can be used to distinguish prostatic cancer from benign
changes [5]. Moreover, DCE MRI parameters can also predict tumor
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score in prostatic cancer [5,6]. According to other reports, K trans and
Ve correlated with glioma grade [7,8].
DCE MRI parameters were also associated with prognosis in
several malignancies [9,10]. Koo et al. showed that breast cancers with
higher K trans or lower Ve had poor prognostic factors and were often
of the triple-negative subtype [10].
According to the literature, DCE MRI parameters can predict
response to therapy in different tumors. For instance, some authors
mentioned that low pretreatment K trans in regional lymph node
metastases in head and neck cancer was associated with a poor
response to concurrent chemoradiation therapy [11].
Furthermore, Andersen et al. showed that DCE MR parameters
obtained prior to chemoradiotherapy predicted survival of patients
with cervical cancer [12].
Presumably, DCE MRI parameters may be based on tissue
composition, such as cellularity and vascular density. However, in this
regard there are contradictory data in the literature. While some
studies identified significant correlations between DCE MRI and
histopathological parameters, others did not [13–16].
The purpose of this study was to correlate DCE MRI findings and
various histopathological parameters in head and neck squamous cell
carcinoma (HNSCC).
Material and Methods
This study was IRB-approved and all patients gave their written
informed consent.
Patients
Sixteen patients (2 women and 14 men, mean age 57.0 ± 7.5 years,
median age 57 years) with histologically proven HNSCC were
included in the study. In 11 cases primary HNSCC and in 5 patients
local tumor recurrence was diagnosed.
Perfusion Measure
In all cases, dynamic contrast-enhanced (DCE) imaging was
performed using T1w DCE sequences according to a protocol
reported previously [17]. T1w DCE included 40 subsequent scans à 6
seconds. Imaging parameters were as follows: TR/TE 2.47/0.97 ms,
slice thickness 5 mm, flip angle 8°, voxel size 1.2 × 1.0 × 5.0 mm. The
contrast application (0.1 mmol Gadobutrol per kg of bodyweight
(Gadovist®, Bayer Healthcare, Leverkusen, Germany)) was started
after the fifth scan at a rate of 3 ml per second and flushing with 10 ml
of normal saline using a power injector (Spectris Solaris, Medrad,
Bayer Healthcare, Leverkusen, Germany). The acquired images were
transferred to a software module for tissue perfusion estimation
(Tissue 4D, Siemens Medical Systems, Erlangen, Germany) as
described previously [17,18]. The software offers a population based
approach for the arterial input function (AIF) and the best of three
available AIF-options was chosen according to the result of the
chi2-parameter, which serves as an error measure for the model fit
[17]. The AIF was scaled in relation to the gadolinium dose and
modeled according to the bi-exponential model of Tofts and
Kermode [19].
The following pharmacokinetic parameters were calculated (for
exemplary parameter images see Figure 1, A-E) [17,18]:
- Ktrans: volume transfer constant which estimates the diffusion of contrast medium
from the plasma through the vessel wall into the interstitial space, representing
vessel permeability;- Ve; volume of the extravascular extracellular leakage space (EES);
- Kep: parameter for diffusion of contrast medium from the EES back to the plasma. It is in
close relation with Ktrans and ve and is calculated by the formula kep = K
trans × Ve
−1;
- iAUC: model-free measurement of the amount of contrast medium delivered to a
VOI within a given time period.
In every case, the four parameter maps were projected onto the
additionally performed T2 weighted fat-suppressed TSE sequences
and the tumor was delineated manually on each slice. This resulted in
mean values of K trans, Kep, Ve and iAUC averaged over the complete
tumor. Areas of gross necrosis or large feeding vessels were avoided.
Histopathological Analysis
In every case, sections from formalin-fixed and paraffin-embedded
tissue were cut at 5 mm and stained with various antigens. The tumor
proliferation index was estimated on Ki 67 antigen stained specimens
by using MIB-1 monoclonal antibody (DakoCytomation, Denmark)
as reported previously [20]. The area with the highest number of
positive tumor nuclei was selected for the analysis (Figure 1F).
Furthermore, microvessel density was estimated on CD31 antigen
stained specimens (DakoCytomation, Denmark) according to the
previous description (Figure 1G) [21].
All stained samples were digitalized by using a research microscope
Jenalumar (Zeiss, Jena, Germany), with camera Diagnostic instru-
ments 4.2., magnification ×400. The digital histopathological images
were transferred as uncompressed TIFF images to ImageJ software
1.48v (National Institutes of Health Image program) with aWindows
operating system [22,23]. The following histopathological parameters
were estimated using the software:
- proliferation index (KI 67) as percentage of stained nuclei;
- cell count as a number of all nuclei;
- stained vessel area (%) calculated as CD 31 positive area divided by the total area of
the analyzed histological specimens;
- total vessel area (%), i.e. percentage of vessel area including stained vessel area (CD
31+) and vessel lumen.
- number of vessels;
- mean vessel diameter, i.e. a sum of all stained vessel diameters divided by the
number of vessels;
In every case, all histopathological parameters were estimated per
two high power fields a 0.16 mm2.
Statistical Analysis
Statistical analysis and graphics creation was performed with SPSS
20 (IBM SPSS Statistics, Armonk, NY, USA). Values are presented as
mean ± SD. Mean value comparison was carried out using the Mann–
Whitney U test. Spearman's non-parametric rank correlation
coefficients were calculated between DCE and different histopath-
ological parameters. Significance level was set at P ≤ .05.
Results
A complete overview of the results including median values and
ranges is shown in Table 1. The mean values of DCE perfusion
parameters were as follows: K trans 0.189 ± 0.056 min−1, Kep 0.390 ±
0.160 min−1, Ve 0.548 ± 0.119%, and iAUC 22.40 ± 12.57.
Histopathological analysis yielded the following results: mean cell
count was 1033.19 ± 361.67 and the mean level of the proliferation
index was 46.25% ± 23.98%. In addition, mean values of tissue
vessels were as follows: stained vessel area 6.259% ± 7.831%, total
Figure 1. Imaging and histopathological findings in primary hypopharyngeal squamous cell carcinoma. (A) Postcontrast, fat-saturatedT1w
image showing a large left-sided cervical mass. (B-E). DCE imaging findings. Estimated DCE parameters are as follows: Ktrans = 0.302
min−1 (B), Kep = 0.470 min−1 (C), Ve = 0.659% (D), IAUC = 41.77% (E). (F) Immunohistochemical stain (MIB-1 monoclonal antibody). Ki
67 index is 75% and cell count is 789. (G) Immunohistochemical stain (CD 31 monoclonal antibody). Estimated microvessel parameters
are as follows: stained vessel area = 0.85%, total vessel area = 1.67%, mean vessel diameter = 15.17 μm, and number of vessels = 28.
Table 1. Analyzed Perfusion and Histopathological Parameters of the Tumors
Parameter M ± SD Median Range
DCE MR parameter
Ktrans 0.189 ± 0.056 0.1785 0.079–0.302
Kep 0.390 ± 0.160 0.3605 0.136–0.636
Ve 0.548 ± 0.119 0.5245 0.372–0.743
IAUC 22.40 ± 12.57 25.97 3.028–41.77
Histopathological parameter
Cell count, n 1033 ± 362 1003 313–1657
Ki 67, % 46.25 ± 23.98 35.00 20–90
Stained vessel area,% 6.259 ± 7.831 2.075 0.77–27.20
Total vessel area, % 7.476 ± 8506 3.687 1.208–30.35
Mean vessel diameter, μm 19.94 ± 7.113 18.34 11.49–35.38
Mean number of vessels, n 53.50 ± 69.41 34.00 15–301
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μm, and mean number of vessels 53.50 ± 69.41 (Table 1).
The results of correlation analysis are shown in Table 2. Significant
correlations were observed between Kep and stained vessel areas (r =
0.51, P = .041) and total vessel areas (r = 0.5118, P = .043); between
Ve and mean vessel diameter (r = −0.59, P = .017). Cell count had a
tendency to correlate with Ve (r = −0.48, P = .058).Table 2. Identified Correlations Between DCE Perfusion and Histopathological Parameters in HNSC
Parameters Ktrans, min
−1 Kep, min
−1
Cell count, n r = −0.12 (P = .65) r = 0.17
Ki 67, % r = −0.16 (P = .56) r = −0,13
Stained vessel area, % r = 0.21 (P = .42) r = 0.51
Total vessel area, % r = 0.24 (P = .38) r = 0.51
Mean vessel diameter, μm r = 0.021 (P = .94) r = 0.39
Mean number of vessels, n r = 0.23 (P = .39) r = 0.14There were no significant correlations between other analyzed
parameters (Table 2).
In an analysis of the primary HNSCC only, a significant inverse
correlation between K trans and KI 67 was identified (r = −0.62, P =
.041). Furthermore, stronger significant correlations were found
between Kep and stained vessel areas, total vessel areas, and between
Ve and mean vessel diameter (Table 3).
Discussion
The present study documents significant correlations between
different DCE MRI and histopathological parameters in HNSCC.
Previously, some studies also analyzed relationships between
histological and perfusion parameters in several malignancies. For
instance, Li et al. showed that the mean K trans and Kep values
significantly correlated with microvessel density in breast cancer [4].
According to Oto et al. Kep positively correlated with the mean blood
vessel count and mean vessel area fraction parameters calculated by
CD31 staining in prostate cancer [13]. Additionally, the mean blood
vessel count and mean vessel area fraction parameters showed a
moderate negative correlation with Ve [13].
However, according to the literature several tumors had different
associations between DCE and histopathological parameters. ForC
Ve, % IAUC
(P = .53) r = −0.48 (P = .058) r = −0.24 (P = .38)
(P = .63) r = −0,061 (P = .82) r = −0,15 (P = .58)
(P = .041) r = −0.38 (P = .14) r = 0,4147 (P = .11)
(P = .043) r = −0.39 (P = .13) r = 0.32 (P = .22)
(P = .13) r = −0,59 (P = .017) r = −0.026 (P = .92)
(P = .61) r = 0.031 (P = .91) r = 0.22 (P = .42)
Table 3. Identified Correlations Between DCE Perfusion and Histopathological Parameters in Primary HNSCC (n = 11)
Parameters Ktrans, min
−1 Kep, min
−1 Ve, % IAUC
Cell count, n r = −0.25 (P = .47) r = 0.0001 (P = .99) r = −0.37 (P = .27) r = −0.29 (P = .37)
Ki 67, % r = −0.62 (P = .041) r = −0.45 (P = .16) r = −0.16 (P = .64) r = −0.49 (P = .129)
Stained vessel area, % r = 0.21 (P = .53) r = 0.67 (P = .02) r = −0.53 (P = .096) r = 0.31 (P = .34)
Total vessel area, % r = 0.07 (P = .83) r = 0.62 (P = .04) r = −0.65 (P = .03) r = 0.29 (P = .38)
Mean vessel diameter, μm r = −0.17 (P = .62) r = 0.43 (P = .18) r = −0.69 (P = .017) r = 0.06 (P = .85)
Mean number of vessels, n r = 0.24 (P = .49) r = 0.23 (P = .49) r = −0.048 (P = .88) r = 0.32 (P = .32)
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correlated with microvessel density in high grade glioma, but not in
low grade tumors [14].
Our results confirmed these findings. We also found statistically
significant positive correlations between Kep and vessel areas in our
cases. Furthermore, Ve correlated inversely with mean vessel diameter.
Moreover, these correlations were stronger in primary tumors.
As reported previously, DCE parameters correlated not only with
vessel density, but also with other tumor markers in different
malignancies. For instance, Aryal et al. reported that Ve significantly
correlated with tumor cellularity in glioma [15]. Jansen et al.
identified a significant correlation between Kep and expression level of
vascular endothelial growth factor in cervical lymph node metastases
from HNSCC [16]. The authors also found that KI 67 inversely
correlated with K trans and Ve [16].
In the present study, we found no significant correlations between
cell count or KI 67 and DCE MRI parameters. Only Ve tended to
correlate with cell count.
However, in the cases with primary tumors K trans correlated
significantly inversely with KI 67. This fact suggests different
associations between DCE parameters and histopathology in primary
versus recurrent tumors.
Similar relationships were reported previously in other malignan-
cies. For instance, perfusions parameters correlated well with KI 67
in glioma, when the data from high and low grade tumors
were combined [24]. However, no significant correlation was
observed in high or low grade tumors, when they were analyzed
separately [24].
The associations between DCE MRI and histopathological
parameters identified in the present analysis may be helpful to
differentiate HNSCC with low and high proliferation potential.
Similarly, the use of DCE MRI can also distinguish tumors with high
angiogenesis from lesions with low microvessel density. Therefore,
DCE MRI parameters can be used as a noninvasive tool for tumor
angiogenesis. In fact, according to Song et al., K trans and Ve values
decreased statistically significantly after anti-angiogenic treatment in
an orthotopic mouse model of human hepatocellular carcinoma [25].
Other authors confirmed these results [26]. This leads to the
assumption that DCE MRI may predict response to anti-angiogenic
therapy. Presumably, tumors with high microvessel density have a
better response to anti-angiogenic drugs.
Clearly, further works with more cases are needed to confirm our
results and to search for other relevant relationships between DCE
and histopathology in different malignancies.
In conclusion, our analysis showed significant correlations between
Kep, Ve and microvessel density in HNSCC. Ve also tended to
correlate with cell count.
In primary tumors, the correlations between Kep, Ve and vessel
parameters were stronger. Furthermore, in primary tumors, K trans
correlated significantly with KI 67.References
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